UwingabiyeJ., LemnouerA., RocaI., et al.2017. Clonal diversity and detection of carbapenem resistance encoding genes among multidrug-resistant Acinetobacter baumannii isolates recovered from patients and environment in two intensive care units in a Moroccan hospital. Antimicrob. Resist. Infect. Cont. 6:1–9.
2.
PoirelL., MansourW., BouallegueO., and NordmannP.. 2008. Carbapenem-resistant Acinetobacter baumannii isolates from Tunisia producing the OXA-58-like carbapenem-hydrolyzing oxacillinase OXA-97. Antimicrob. Agents Chemother. 52:1613–1617.
3.
CoelhoJ., WoodfordN., Afzal-ShahM., and LivermoreD.. 2006. Occurrence of OXA-58-like carbapenemases in Acinetobacter spp. collected over 10 years in three continents. Antimicrob. Agents Chemother. 50:756–758.
4.
PoirelL., and NordmannP.. 2006. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin. Microbiol. Infect. 12:826–836.
5.
BakourS., AlsharapyS.A, TouatiA., and RolainJ.M.. 2014. Characterization of Acinetobacter baumannii clinical isolates carrying bla carbapenemase and 16S rRNA methylase armA genes in Yemen. Microb. Drug Resist. 20: 604–609.
6.
MathlouthiN., AreigZ., Al BayssariC., et al.2015. Emergence of carbapenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii clinical isolates collected from some Libyan hospitals. Microb. Drug Resist. 21: 335–341.
7.
ClelandD.A., and ErankiA.P. 2021. Procalcitonin. [Updated September 3, 2020]. In: StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL, 2021. Available at https://www.ncbi.nlm.nih.gov/books/NBK539794/